Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease
Clinical trial NCT02574286 · COMPLETED
Trial details
- NCT number
- NCT02574286
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-29
- Primary completion
- 2020-11-12
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.